Tizona Therapeutics
Latest round
- Series B
Last raised
- Feb 2016
Total raised
- $70M
Investors
- 7
About Tizona Therapeutics
Tizona Therapeutics, Inc.Founded in 2014 and headquartered in San Francisco, US, Tizona Therapeutics is focused on developing immunotherapy treatments. In July 2020, Gilead Sciences, Inc.25 bn. The firm has completed 3 deals since its inception, with the most recent deal occurring on July 21, 2020.Tizona Therapeutics develops innovative immunotherapies aimed at improving cancer treatment outcomes. Their lead product, TTX-080, is designed to enhance the effectiveness of treatments like the EGFR inhibitor Cetuximab and chemotherapy for advanced colorectal cancer.Tizona Therapeutics primarily generates revenue through partnerships with healthcare institutions and pharmaceutical companies for clinical trial collaborations. The company's revenue model includes milestone payments based on achieving clinical endpoints and royalties on future sales upon regulatory approval. to advance its immunotherapy product development and potentially expand into new geographic markets. The focus is on launching new products, including TTX-080, and enhancing their clinical trials. The recent investment of USD 300 mn will support these initiatives while also aiming for strategic collaborations in North America and Europe, which are targeted for expansion in the coming years.
Who invested in Tizona Therapeutics
7 investors across 2 rounds
See all investors in Tizona Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tizona Therapeutics
Who invested in Tizona Therapeutics?
Tizona Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tizona Therapeutics raised?
Tizona Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tizona Therapeutics last raise money?
Tizona Therapeutics's most recent round on record is a Series B, in Feb 2016.
What does Tizona Therapeutics do?
Tizona Therapeutics is a biotechnology company.
Where is Tizona Therapeutics headquartered?
Tizona Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Tizona Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tizona Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tizona Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.